Aristo Bio-Tech And Lifescience Limited — Others, 29-06-2025: Disclosure under SEBI Takeover Regulations

The company has announced a board meeting to consider approving the financial results for the quarter and half-year. This meeting decision is relevant as it will provide shareholders and investors with updated insights into the company’s recent financial performance, potentially impacting stock valuation and investor confidence. No additional operational changes or material updates were disclosed.